Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
NCT06482515 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2025-07-03
Summary
Cancer-related fatigue affects at least 30-90% of patients with cancer, depending on the type of cancer and their treatment(s) (e.g., chemotherapy, radiation). It is not relieved by sleep or rest, and it sometimes can persist for years after a person's cancer was treated. The fatigue can be so bad that people cannot return to work, hobbies, family roles, or other daily activities, thereby greatly reducing quality of life. The causes of this fatigue are unknown, and we currently do not have anything that can reliably prevent or cure the fatigue. However, there are recent data suggesting that circadian rhythm, or a person's internal body clock, may be disrupted by the cancer experience and contribute to fatigue. Food intake is an external cue that can entrain circadian rhythm. We recently showed that cancer survivors are willing and able to eat all their food within a 10-hour eating window-a practice called time-restricted eating. Herein, we are testing time-restricted eating against a control group (matched for time-, attention, and expectancy) to see if time-restricted eating can indeed alleviate cancer-related fatigue. All participants will be asked to use the myCircadianClock smartphone app to log their food intake and weekly body weight measurements. The participants assigned to the time-restricted eating group will be asked to eat all their food in a 10-hour window during the day. People can choose their start time based on their schedule and preferences, but we ask that the window is the same for the whole study (e.g., 7am-5pm,9:30am-7:30pm). Black coffee and unsweetened tea are allowed before the eating window, and water and medicines are allowed at all times. The participants in the control group will meet with a nutritionist to discuss the American Cancer Society nutrition guidelines in cancer survivorship; they will not be restricted to when they can eat. Participants in both groups will give us valuable information regarding how diet is related to the experience of fatigue. The purpose of this study is to test the effects of a 12-week TRE intervention vs. an unrestricted eating pattern on fatigue, the sustainability of the program at 24 weeks, and the effects of TRE on circadian rhythm and sugar metabolism.
Conditions
- Neoplasms
- Blood Cancer
- Fatigue
- Diet Habit
- Survivorship
- Fasting, Intermittent
Interventions
- BEHAVIORAL
-
Time-restricted eating
Participants will be asked to eat all their food in a self-selected 10-hour eating window every day.
- BEHAVIORAL
-
Nutrition counseling
Participants will meet with a nutritionist to discuss their dietary habits and how they compare to the American Cancer Society nutrition guidelines.
Sponsors & Collaborators
-
University of Maryland, Baltimore
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-04
- Primary Completion
- 2028-05-01
- Completion
- 2028-08-31
Countries
- United States
Study Locations
More Related Trials
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
NCT06855524 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Ketamine on Fatigue Following Cancer Therapy
NCT02317341 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
NCT03407716 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery
NCT04029857 ·Status: WITHDRAWN ·Phase: PHASE3
-
Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
NCT06819254 ·Status: RECRUITING ·Phase: PHASE4
-
Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer
NCT00925899 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
NCT02592447 ·Status: COMPLETED ·Phase: NA
-
Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer
NCT01175837 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
NCT02645175 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
NCT02361125 ·Status: COMPLETED ·Phase: PHASE1
-
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
NCT00042848 ·Status: COMPLETED ·Phase: PHASE3
-
Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors
NCT02452710 ·Status: TERMINATED ·Phase: NA
-
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)
NCT03700437 ·Status: COMPLETED ·Phase: NA
-
Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant
NCT02590107 ·Status: TERMINATED ·Phase: NA
-
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
NCT00769652 ·Status: TERMINATED ·Phase: NA
-
Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN)
NCT03058107 ·Status: COMPLETED ·Phase: NA
-
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial
NCT06438588 ·Status: RECRUITING ·Phase: NA
-
The Analysis of Fatigue on Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukaemia
NCT06233890 ·Status: ACTIVE_NOT_RECRUITING
-
American Ginseng in Treating Patients With Fatigue Caused by Cancer
NCT00719563 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue
NCT00555841 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
NCT00053053 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
NCT03143894 ·Status: TERMINATED ·Phase: NA
-
Modafinil in Treating Fatigue in Patients With Cancer
NCT00112515 ·Status: UNKNOWN ·Phase: NA
-
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
NCT02522988 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of a Web-Based Automated Self-Administered 24-hour Dietary Recall (ASA 24) and a Physical Activity 24-hour Recall
NCT01164254 ·Status: COMPLETED